AstraZeneca’s Remarkable Resilience: A Silver Lining Amid Market Turbulence
AstraZeneca's stock rose by 16% in 2023 despite a volatile stock market environment, indicating its strong market position. In 2022, AstraZeneca's revenue increased by 18% to £54.1 billion, with a…